Summary: Indomethacin is a potent inhibitor of pros taglandin synthesis. Indomethacin effects on cerebral blood flow (CBP) in normal subjects and patients with ischemic cerebrovascular disease were measured by 133Xe inhalation method and compared. Thirteen normal sub jects with muscle contraction headaches were tested and compared to three groups of patients with ischemic cere brovascular disease: (1) a transient ischemic attack (TlA) group, consisting of 8 patients, (2) a recent cerebral in farction group consisting of 10 patients with recent stroke (within 2 months) , and (3) a chronic cerebral infarction group, consisting of 10 patients with remote stroke (ex ceeding 2 months) . Prom the three groups, 7 patients with internal carotid artery occlusion also underwent superfi cial temporal artery to middle cerebral artery (ST A -M CAl bypass; this group was tested before and after the opera tive procedure. Indomethacin induced significant CBP reductions in the TlA and chronic cerebral infarction groups but there were no significant effects in the recent cerebral infarction group and many showed paradoxical It has become well established in the past decade that prostaglandins are potent vasoactive agents and play an important role in cerebrovascular con trol and neural function (Moncada and Vane, 1979; Wolfe and Coceani, 1979; Pickard, 1981) . Prostacy clin, particularly, participates in cerebrovascular homeostasis in health and disease as one of the most potent cerebral vasodilators and inhibitors of platelet aggregation discovered to date (Moncada et ai., 1976; Herman et ai., 1977; Moncada and Vane, 1979) . On the other hand, thromboxane A2 is a po tent vasoconstrictor and platelet aggregating agent. It is synthesized by platelets and appears to trigger 115 increases. Plotting indomethacin-induced CBP changes according to the time course of cerebral infarction indi cated that abnormal responses gradually returned toward normal within 16 weeks. Indomethacin-induced CBP changes were measured prospectively in patients under going STA-MCA bypass. Indomethacin had no significant effect on CBP before the procedure, but significantly re duced CBP (i. e. , mean CBP became reduced) after sur gery. Comparison of the time course for recovery of indomethacin-induced CBP responses in non-operated cases indicated that the post-operative difference in re sponse could be due to the natural history of the disease rather than to surgery. Present studies confirm that pros taglandins play an important " part in cerebral vascular control in man, and that these agents are temporarily de ranged following acute cerebral infarction, which may ac count for temporary alterations in regional cerebrovas cular responsiveness to 5% CO2 and 100% O2 inhalation after stroke. Key Words: Cerebral blood flow Ischemia-Prostaglandins.
the majority of transient cerebral ischemic attacks (TIAs) and episodes of infarction (Moncada and Vane, 1979; Pickard, 1981) . Indomethacin is about 20-60 times as potent as aspirin in inhibiting pros taglandin synthesis from arachidonic acid, by blocking the enzyme cyclooxygenase (Vane, 1971; Flower, 1974; Amano and Meyer, 1982) . Several reports are now available indicating that, in both human and animal experiments, indomethacin re duces cerebral blood flow (CBF) and cerebral va somotor responsiveness to an inhaled mixture of 5-7% carbon dioxide and 100% oxygen, without altering cerebral metabolism or cerebral autoregu lation (Pickard and Mackenzie, 1973; Pickard et ai. , 1977a,b; Sakabe and Siesjo, 1979; Dahlgren et ai., 1981; Amano and Meyer, 1982; Crockard et ai., 1982; Harris et ai., 1982) . Although prostaglandin synthesis is known to be altered by cerebral isch emia in animal models and this in turn has been shown to be modified by administration of in domethacin, the effect of indomethacin on cerebral hemodynamics in patients with cerebral ischemia has not been investigated. Table 1 , a control group was selected which consisted of 13 normal subjects complaining of muscle contraction headache. There were 11 males and 2 females with a mean age of 43.8 ± 14.9 years. The patient groups all suffered from occlu sive cerebrovascular disease and were subdivided into three groups based on the history, clinical signs and symptoms, computerized tomographic scans, and cerebral angiographic findings. Group 1 con sisted of 8 patients with TIAs (7 males and 1 female) with a mean age of 60.0 ± 6.6 years. Group 2 con sisted of 10 patients with recent cerebral infarction (8 males and 2 females). These patients had all suf fered either recent reversible ischemic neurologic deficits, with prolonged focal neurological deficits lasting 1-2 months in duration but with complete or almost complete recovery, or small strokes, with mild persistent defects within 2 months of the ictus. This patient group had a mean age of 53.1 ± 11.9 years at the time of CBF measurement. Group 3 consisted of 10 patients with remote reversible isch emic neurologic deficits or small strokes which had 1983 occurred 2 months or more before CBF testing. There were 9 males and 1 female with a mean age of 57. 6 ± 6.0 years. From the three groups, 7 patients with complete occlusion of one internal carotid ar tery also underwent superficial temporal artery to middle cerebral artery (STA-MCA) bypass surgery in an effort to prevent further TIAs and strokes. There were 5 males and 2 females in the STA-MCA bypass group, with a mean age of 55.3 ± 7.5 years. The patients were withdrawn from all medications for at least 24-48 h prior to CBF testing. All signed informed-consent forms prior to the procedures, as approved by the Institutional Review Board of Baylor College of Medicine and the Veterans Ad ministration Medical Center.
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METHODS
Regional cerebral blood flow responsiveness before and after indomethacin was measured by the 13:JXe inha lation method as originally proposed by Obrist et aI. , 1975 , but modified in this laboratory for clinical applica tion (Meyer et aI. , 1978) . A tracer mixture of 13:1Xe gas (3-7 mCi/L) in room air was inhaled for 1 min and clear ance of the isotope from the brain was monitored throughout the following 10 min by means of 16 colli mated NaI crystal scintillation detectors applied over the scalp. After correction for arterial recirculation, flow val ues were calculated by means of a PDP 11105 minicom puter as the fast component of clearance or gray matter flow (F1) (Meyer et aI. , 1978) . Analysis of all data was based on mean hemispheric F lor gray matter flow values. Pulmonary end-tidal (PE) CO2, O2, and 133Xe values were recorded concurrently on a polygraph, and blood pres sure, respiration, electroencephalogram, and electrocar diogram were also monitored throughout the CBF mea surements.
Measurements were made first in the resting or steady state before oral administration of indomethacin. After the resting measurement was completed, one or two cap sules of indomethacin (25 -50 mg) were given to the nor mal control subjects as well as to the patients with isch emic cerebrovascular disease. At least 40 min after ad ministration, a second measurement was performed. The mean indomethacin dose for controls was 0.57 ± 0.09 mg/kg. The dose for patients with TIAs was 0.65 ± 0.09 mg/kg; for recent stroke cases, 0.63 ± 0.13 mg/kg; and for chronic stroke patients, 0.63 ± 0.12 mg/kg. There were no significant differences for indomethacin dosage among the different groups (Table 1 ) . In the 7 patients who underwent STA-MCA bypass, indomethacin CBF tests were made before and after surgery. All differences among mean data values were analyzed for statistical sig nificance by Student's t test.
RESULTS
Mean F 1 values (average F 1 of both hemispheres) and corresponding mean arterial blood pressure and PE CO2 values, before and after administration of indomethacin, are compared for each group in Table 2 . Although individual regional probe changes are available, only mean hemispheric flow data will be discussed because of greater ease in handling statistical data by this means of analysis. Percent changes for Fl values (�%) induced by indometha cin in normal controls was -21.2 ± 13.3%; for TIA cases, -19.6 ± 11.2%; for recent strokes, +5.7 ± 9.4%; and for chronic stroke patients, -18.7 ± 12.8%. These changes showed statistically signifi cant reductions in all groups except the recent stroke group (controls, p < 0.001; TIAs and chronic cerebrovascular disease patients, p < 0.01). Mean arterial blood pressure and PE CO2 values before and after administration of indomethacin showed no significant changes. Table 3 gives mean Fl values and percent change of F 1 before and after in domethacin for the ischemic and contralateral hemispheres for the three ischemic patient groups. Significant changes of F 1 values for both hemi spheres were shown in the TIA and chronic stroke groups (p < 0.01-0.05), but not for the recent stroke group. There were no significant interhemi spheric differences between Fl values or Fl percent change induced by indomethacin among the differ ent groups. Percent changes of mean Fl values in duced by indomethacin administration in normal subjects and in patient groups with cerebral isch emia are compared in Fig. 1 . There were significant differences in percent change of mean F 1 values in duced by indomethacin between recent stroke groups and all other groups (p < 0.001), but there were no significant differences in responses among any of the other groups. The recent stroke group showed numerous examples of paradoxical in domethacin effects, with increases in regional mean F 1 values which were not seen in any of the other groups. Figure 2 illustrates the time course of induced indomethacin responses expressed as percent change of mean F I values in patients with recent and chronic stroke plotted against time. It may be noted that the indomethacin CBF responses were more severely impaired in the most acute stroke patients; thereafter, there was a gradual restoration of the indomethacin responses toward normal. About 16 weeks after the stroke, indomethacin induced responses were within normal limits. STA-MCA bypass surgery was performed in 7 patients with recent and remote cerebral ischemia. Indomethacin effects on mean FI, mean arterial blood pressure, and PE CO2 values before and after bypass surgery are illustrated in Table 4 . Significant reductions of mean F 1 values induced by in domethacin that were not observed before the oper ation were apparent after surgery (p < 0.01). There were no significant changes in mean arterial blood pressure and PE CO2 values induced by indometha cin before or after surgery. The mean time interval that elapsed between the pre-and post-operation CBF test measurements was 3 months. Table 5 and Fig. 2 summarize mean F 1 values expressed as per cent change induced by indomethacin before and after the internal carotid bypass procedure. Signifi cant restoration of indomethacin CBF responsive ness was noted after surgery for both hemispheres, expressed as the mean (p < 0.05), and for the mean values for hemispheres contralateral to the bypass (p < 0.02), but there were no significant changes for indomethacin-induced CBF responses within the hemisphere undergoing the bypass. Before conclu sions are drawn, it should be noted that the mean time lapse between stroke and pre-operative test ing was 8.6 ± 7.3 weeks; between pre-operative tests and surgery, 1.9 ± 2.0 weeks; and between surgery and post-operative testing, 12.0 ± 3.5 weeks. Comparison of results in the operated group were compared with the time course of recovery noted in the non-operated subjects. Restoration of indomethacin CBF responsiveness in patients un dergoing STA-MCA bypass was only 6% greater than that of the natural recovery measured over the same time interval in non-operated cases, as esti mated by the line of regression (Figs. 2 and 3) . Since the non-operated cases showed a regression line with an SD of 12.6%, the 5% difference in the oper ated group was not statistically significant.
DISCUSSION
The vasomotor action of certain of the prosta glandins may vary with the nature of the vascular bed upon which they are tested (Wolfe and Coceani, 1979) . For example, PGE2 and PGF2 reduce CBF and the cerebral metabolic rate for oxygen in the baboon, while at the same time PGE2 increases -6.9 ± 9.3 -19.7± 10.9 -10.4 ± 8.9 -17.6±11.2 -3.7 ± 11.6 -21.6 ± 11.7 Paired t test p < 0.05 ns p < 0.02 extracranial blood flow (Pickard et aI. , 1977a,b) . However, prostacyclin (PGI2) and thromboxane A2 are consistent and potent vasodilator and vaso constrictive agents, respectively, at all sites test ed. Prostacyclin is the major product of cyclo oxygenase activity of vessel walls, especially the intima (Herman et aI. , 1977) , and is potent in pre venting platelet aggregation as well as in exerting a vasodilator action. Thromboxane A2 is synthesized only by platelets and is a potent platelet aggregating agent as well as vasoconstrictor (Moncada and Vane, 1979; Wolfe and Coceani, 1979; Pickard, 198 1) . Prostaglandins have been shown to play an important role in control of vascular tone as well as in the regulation of CBF.
Indomethacin inhibits prostaglandin biosynthesis by blocking cyclooxygenase (Flower, 1974) , and its inhibiting effects have been estimated to be at least 23 times (Vane, 197 1) or as much as 60 times (Amano and Meyer, 1982) as potent as those of aspi rin. Absorption of indomethacin by oral adminis tration is rapid (peak concentration time, 30 min -2 h), and plasma concentrations reach almost identi cal levels when given by mouth as after intravenous administration (Alvan et aI., 1975) . At least 1 p,g/kg of indomethacin, at the tissue level, is required for measurable inhibition of prostaglandin synthesis, and the brain tissue versus plasma ratio for in domethacin is 0.02 (Vane, 197 1; Pickard and Mac kenzie, 1973) . The average indomethacin dosage in our patients was between 0.57 and 0.65 mg/kg, which may be expected to produce sufficient plasma concentrations to inhibit prostaglandin synthesis. The CBF tests were all performed at least 40 min after administration of indomethacin at a time when peak plasma concentrations are achieved.
In the control group of normal subjects, in domethacin significantly reduced resting F 1 values by -2 1.2 ± 13.3%. The effects were homogeneous from probe to probe. These results are in good agreement with previous reports (Pickard and Mac kenzie, 1973; Pickard et aI. , 1977a,b; Sakabe and Siesjo, 1979; Dahlgren et aI. , 198 1; Amano and Meyer, 1982; Crockard et aI., 1982; Harris, et aI., 1982) . As shown in Tables 2 and 3, and Fig. 1 , pa tients with TIAs and chronic stroke likewise showed reductions of mean F 1 values after in domethacin ingestion (-18. 6 ± 11.2%; -18. 7 ± 12. 8%, respectively). There were no significant differences for percent F 1 changes induced by in domethacin between controls and TIA or chronic stroke groups.
On the other hand, patients with recent infarc tions occurring within 2 months of CBF testing showed paradoxical F 1 increases induced by in domethacin of + 5. 7 ± 9. 4%. Individual probes re cording regional CBF values over the zone of in farction showed maximal increases. With the pas sage of time after an acute stroke the indomethacin effect on CBF was gradually restored toward nor mal, reaching normal limits about 16 weeks after the stroke (Fig. 2) .
Several previous reports have shown that cerebral vasodilator responses to CO2 are impaired in pa tients with acute strokes, presumably because cere bral vessels were already maximally dilated due to tissue acidosis with vasoparalysis (Hoedt-Ras mussen et aI., 1967; Fieschi et aI., 1968) . These abnormal responses to CO2 likewise recover toward normal levels several weeks after a stroke (Halsey and Clark, 1970) . Prostaglandins, possibly mainly prostacyclin, are required for hypercapnia to pro duce normal cerebral vasodilatation (Pickard et aI., 1977a,h; Pickard et aI., 1980; Dahlgren et aI., 198 1; Amano and Meyer, 1982) . Prostaglandin metabo lism generates free radicals which appear to be nec essary for ionic fluxes at the smooth muscle mem brane (Chaplean et aI., 1980) . These ionic fluxes are the final common pathway for all cerebral vaso motor reactivity, including CO2 responses induced by changes in smooth muscle pH (Yamamoto and Meyer, 1980; Crockard et aI., 1982) .
Phospholipase A2 activity is stimulated by isch emia (Hsueh et aI., 1977; Gaudet and Levine, 1979; Pickard, 198 1) with release of free fatty acids and in organic phosphate (Meyer et aI., 1975) . This en zyme produces arachidonic acid, which is the pre cursor for all prostaglandins and is mainly derived from phospholipids of vessel membranes (Pickard, 198 1) . Thus, prostaglandin synthesis and release are stimulated by brain hypoxia and ischemia (Meyer et aI., 1975; Ruszczewski and Herbackzynska-Cedro, 1978; McCalden et aI., 1983) and this may lead to uncoupling of CBF from cerebral metabolism (Meyer et aI., 1975; Pickard, 198 1) . Taken together, these facts permit the conclusion that enhanced prostaglandin synthesis and release by the brain are stimulated by ischemia and occur as a result of acute stroke. This overproduction and displacement of prostaglandins, combined with accumulation of CO2 and hydrogen ions in the presence of abnormal free radical metabolism, results in impaired vaso motor responsiveness and vasoparalysis. In such a situation, normal indomethacin responses would be expected to be abolished and this proved to be the case in the present investigation. Our results also suggest that in man, as in animal experiments (Kel logg and Fridovich, 1975; Siesjo, 1978; Kontos et aI., 1980; Yoshida et aI., 1980) , as ischemia sub sides, lipid peroxidation, abnormal prostaglandin metabolism, and free radical generation are restored to normal, as evidenced by recovery of normal CBF responses to indomethacin.
